- Home
- RPRX vs ELS Comparison
RPRX vs ELS Comparison
Compare RPRX & ELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- ELS
- Stock Information
- Founded
- RPRX 1996
- ELS 1992
- Country
- RPRX United States
- ELS United States
- Employees
- RPRX N/A
- ELS N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- ELS Real Estate Investment Trusts
- Sector
- RPRX Health Care
- ELS Real Estate
- Exchange
- RPRX Nasdaq
- ELS Nasdaq
- Market Cap
- RPRX 14.2B
- ELS 12.3B
- IPO Year
- RPRX 2020
- ELS 1993
- Fundamental
- Price
- RPRX $33.10
- ELS $63.76
- Analyst Decision
- RPRX Strong Buy
- ELS Buy
- Analyst Count
- RPRX 4
- ELS 9
- Target Price
- RPRX $42.50
- ELS $74.33
- AVG Volume (30 Days)
- RPRX 3.9M
- ELS 1.5M
- Earning Date
- RPRX 05-08-2025
- ELS 04-21-2025
- Dividend Yield
- RPRX 2.66%
- ELS 3.12%
- EPS Growth
- RPRX 37.42
- ELS 5.86
- EPS
- RPRX 2.45
- ELS 1.94
- Revenue
- RPRX $2,263,576,000.00
- ELS $1,537,798,000.00
- Revenue This Year
- RPRX $31.30
- ELS $2.78
- Revenue Next Year
- RPRX $5.82
- ELS $3.87
- P/E Ratio
- RPRX $13.52
- ELS $32.83
- Revenue Growth
- RPRX 1.12
- ELS 1.94
- 52 Week Low
- RPRX $24.05
- ELS $58.86
- 52 Week High
- RPRX $34.20
- ELS $76.60
- Technical
- Relative Strength Index (RSI)
- RPRX 57.01
- ELS 44.71
- Support Level
- RPRX $31.97
- ELS $63.55
- Resistance Level
- RPRX $33.00
- ELS $65.23
- Average True Range (ATR)
- RPRX 0.71
- ELS 1.38
- MACD
- RPRX 0.08
- ELS 0.10
- Stochastic Oscillator
- RPRX 60.08
- ELS 49.25
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About ELS Equity Lifestyle Properties Inc.
Equity Lifestyle Properties is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company currently has a portfolio of 452 properties across the U.S. with a higher concentration in the Sunbelt region with 38% of the company's properties located in Florida, 12% in Arizona, and 8% in California. Equity Lifestyle targets owning properties in attractive retirement destinations with over 70% of the company's properties either being age-restricted or having an average resident age over 55.